CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,017,000 | -28.1% | 22,372 | -16.5% | 0.36% | -60.1% |
| Q1 2018 | $1,414,000 | -0.6% | 26,777 | +28.1% | 0.91% | -21.3% |
| Q4 2017 | $1,422,000 | +2.1% | 20,906 | +23.7% | 1.15% | -19.6% |
| Q3 2017 | $1,393,000 | +8.7% | 16,900 | +23.4% | 1.43% | -10.4% |
| Q2 2017 | $1,282,000 | +86.3% | 13,690 | +26.7% | 1.60% | +35.7% |
| Q1 2017 | $688,000 | -7.9% | 10,805 | -47.9% | 1.18% | +126.5% |
| Q3 2016 | $747,000 | – | 20,730 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |